UNSPSC 51453301: Dixanthogen

This classification denotes a pesticide with the molecular formula C6H10O2S4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RN4CQ46FDM, chemically known as xanthogen, bis(ethyl- but generally known as dixanthogen, which bears US NIH Compound Identifier 10404. European Medicines Agency schedules Dixanthogen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06339MIG. The term DIXANTHOGEN is an International Non-Proprietary Name.

UNSPSC 51453301 Dixanthogen, a Commodity code, does not align with recent state and local procurement activity. The two opportunities tagged under this code involve pharmaceutical products—Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets through Illinois Department of Public Health, and Naloxone and drug deactivation systems through Seminole County, Florida—neither of which relates to dixanthogen, a flotation reagent used in mineral processing and mining. The mismatch suggests these opportunities were miscoded in the source system or that the code has been repurposed inconsistently by issuing bodies.

Activity under this code shows no relevant recent opportunities for vendors in the dixanthogen space. Illinois Department of Public Health awarded a $2,999,999.11 contract to Chartwell Rx LLC on August 28, 2026, for pharmaceutical supply through the MMCAP Infuse cooperative purchasing consortium, and Seminole County released an IFB on June 30, 2026, for Naloxone and drug deactivation systems with a July 26, 2023, response date—both procurement actions disconnected from chemical reagent supply. Business development professionals should verify the correct UNSPSC code for dixanthogen sourcing rather than pursue opportunities under this Commodity code, as current tagging does not reflect genuine demand in the category.